Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
Fairview University Medical Center
mi
from
Minneapolis, MN
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
Fairview University Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
New York Columbia Presbyterian Hospital
mi
from
New York, NY
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
New York Columbia Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal
mi
from
Houston, TX
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal
mi
from
Houston, TX
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated:  12/31/1969
St. Luke's Medical Center
mi
from
Milwaukee, WI
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: Enrolling
Updated: 12/31/1969
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Washington,
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Valhalla, NY
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Valhalla, NY
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
A Phase II, Single-blind, Randomised, Placebo-controlled Trial to Study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody Administered as Adjunctive Treatment to Patients With Acquired Thrombotic Thrombocytopenic Purpura
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital
mi
from
Los Angeles, CA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Huntington Memorial Hospital
mi
from
Pasadena, CA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Huntington Memorial Hospital
mi
from
Pasadena, CA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Regional Cardiology Associates
mi
from
Sacramento, CA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Regional Cardiology Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Delta Heart and Medical Clinic
mi
from
Stockton, CA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Delta Heart and Medical Clinic
mi
from
Stockton, CA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
University of Colorado Health - MHS
mi
from
Colorado Springs, CO
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health - MHS
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Bridgeport Hospital
mi
from
Bridgeport, CT
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Washington Electrophysiology/Cardiovascular Research Institute
mi
from
Washington,
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Washington Electrophysiology/Cardiovascular Research Institute
mi
from
Washington,
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Bay Area Cardiology Associates, P.A.
mi
from
Brandon, FL
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Bay Area Cardiology Associates, P.A.
mi
from
Brandon, FL
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Watson Clincia Center for Research Inc.
mi
from
Lakeland, FL
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Watson Clincia Center for Research Inc.
mi
from
Lakeland, FL
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Tallahassee Research Institute
mi
from
Tallahassee, FL
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Tallahassee Research Institute
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Georgia Health Sciences University
mi
from
Augusta, GA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Georgia Arrhythmia Consultants
mi
from
Macon, GA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Georgia Arrhythmia Consultants
mi
from
Macon, GA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
University of Chicago Hospital
mi
from
Chicago, IL
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
University of Chicago Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Peakview Research Center
mi
from
Fort Wayne, IN
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Peakview Research Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
LaPorte Hospital
mi
from
Hobart, IN
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
LaPorte Hospital
mi
from
Hobart, IN
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Louisiana State University Health Sciences Center- New Orleans
mi
from
New Orleans, LA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Louisiana State University Health Sciences Center- New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
MedStar Southern Maryland Hospital Center
mi
from
Clinton, MD
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
MedStar Southern Maryland Hospital Center
mi
from
Clinton, MD
Click here to add this to my saved trials
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated:  12/31/1969
Tufts - New England Medical Center
mi
from
Boston, MA
Ranolazine Implantable Cardioverter-Defibrillator Trial
Late Sodium Current Blockade in High-Risk ICD Patients
Status: Enrolling
Updated: 12/31/1969
Tufts - New England Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials